患有默克尔细胞癌的患者多种原发性癌症的风险:基于SEER的分析
Edward Eid1, Nolan J Maloney2, Zhuo Ran Cai1
1Program for Clinical Research and Technology, Department of Dermatology, Stanford University School of Medicine, Stanford, California.
JAMA dermatology
|September 13, 2023
概括
被诊断为默克尔细胞癌 (MCC) 的患者面临患上后续癌症的风险增加,包括黑色素瘤,甲状腺癌和非霍奇金淋巴瘤. 这一发现凸显了进一步研究共同原因和改善患者监测的必要性.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 在默克尔细胞癌 (MCC) 诊断后,患上二次原发性癌症的风险还不清楚.
- 了解这些风险对于患者的管理和预后至关重要.
研究的目的:
- 调查先前被诊断患有皮肤默克尔细胞癌 (MCC) 的个体后续原发性癌症的风险.
主要方法:
- 一项队列研究,利用来自17个监测,流行病学和最终结果 (SEER) 计划注册表的数据.
- 分析包括6146名在2000年至2019年期间被诊断患有首次原发性皮肤MCC的患者.
- 使用标准化发病率 (SIR) 和过度风险来计算相对和绝对风险.
主要成果:
- 患有MCC的患者显示后续癌症的风险增加 (SIR=1.28).
- 观察到特定固体瘤的风险增加,包括皮肤黑色素瘤 (SIR=2.36) 和乳头甲状腺癌 (SIR=5.26).
- 在非霍奇金淋巴瘤 (SIR=2.62) 中,血液癌症风险显著增加.
结论:
- 患有MCC的个体有更高的发展后续固体和血液恶性瘤的可能性.
- 潜在的促成因素包括增加医疗监测,癌症治疗或共同的潜在病因因素.
- 建议进行进一步的研究,以探索将MCC与其他癌症联系在一起的常见原因.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


